An increasing number of organizations are using Six Sigma to sell and market pharmaceuticals, and a December forum will focus on this new trend. Standardizing and improving the quality of pharmaceutical sales and marketing is more important now than ever as the industry faces increasing regulations. Failure to meet compliance standards can result in severe penalties, delayed developments and significant costs.

With this situation in mind, the Strategic Research Institute will present its Six Sigma for Sales and Marketing in Pharmaceuticals forum Dec. 7–8 in Philadelphia. Experts will demonstrate how applying the methodology can improve sales and streamline marketing in the pharmaceutical industry. In addition, attendees will learn how to leverage current resources to support Six Sigma implementation, ensure senior management support, modify Six Sigma to fit the pharmaceutical industry, choose the right people for the right projects and successfully deploy the methodology into the fabric of an organization.

Representatives from major pharmaceutical companies like Johnson & Johnson Healthcare Systems Inc., Wyeth BioPharma and Wyeth Pharmaceuticals, Crane Co., and Ethicon Inc. will present case studies detailing their quality efforts.

 …